ストックスクリーナーアプリを入手
0.421
0.00%
0.00
Silo Pharma Inc (SILO) 最新ニュース
Silo Pharma files patent for ibogaine-based TBI treatment - Investing.com
Silo Pharma files patent for ibogaine-based TBI treatment By Investing.com - Investing.com Canada
With no FDA-approved TBI drugs, Silo pursues ibogaine therapy - Stock Titan
Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury - GlobeNewswire
Silo Pharma rallies after securing key patent allowance - MSN
SILO Stock Price, Quote & Chart | SILO PHARMA INC (NASDAQ:SILO) - ChartMill
SILO Silo Pharma reports wider-than-expected Q4 2023 loss, shares dip 1.62% amid weak investor sentiment.Acquisition - Newser
Washington speeds psychedelic PTSD work as Silo spotlights program - Stock Titan
Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD - Sahm
Why did SILO stock soar 85% today? - MSN
Levi Strauss, Greenbrier and 3 stocks to watch heading into Tuesday - MSN
SILO Silo Pharma rises 5.57 percent despite reporting a wider than expected Q4 2023 per share loss.Gross Margin - Newser
CMND stock set for biggest intraday gains in over three years — here’s why retail is eyeing further upside - MSN
SILO Price Today: Silo Pharma, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Silo Pharma launches AI subsidiary, advances PTSD drug program By Investing.com - Investing.com India
Silo Pharma Diversifies into AI with Qwikagents Asset Acquisition, Targeting $47-53 Billion Market - citybuzz -
Silo Pharma Inc. posts 76.5% EPS miss with no reported revenueDividend Initiation - Cổng thông tin điện tử tỉnh Tây Ninh
Silo Pharma launches AI subsidiary, advances PTSD drug program - Investing.com
Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents - The Manila Times
A biotech advancing a PTSD drug just bought an AI agent platform - Stock Titan
Silo Pharma Announces Strategic Business Expansion Into Multi-Billion Dollar AI Agent Market With Acquisition of Managed AI Agent Platform, Qwikagents - 富途牛牛
Silo Pharma, Inc. acquired Assets of Qwikagents.ai. - marketscreener.com
Silo Pharma highlights PTSD treatment program amid policy shift By Investing.com - Investing.com India
Silo Pharma highlights PTSD drug program amid policy shift By Investing.com - Investing.com India
Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics - marketscreener.com
Silo Pharma (SILO) Stock Payout Ratio (Momentum Building) 2026-04-20Buy Signals - Cổng thông tin điện tử tỉnh Tây Ninh
Silo Pharma highlights PTSD drug program amid policy shift - Investing.com
Silo Pharma highlights PTSD treatment program amid policy shift - Investing.com
Silo Pharma Positioned to Advance Treatment Targeting PTSD - GlobeNewswire
What's going on in today's after hours session - ChartMill
Silo Pharma (SILO) Stock VWAP Break (+1.18%) 2026-04-18Community Breakout Alerts - Cổng thông tin điện tử tỉnh Lào Cai
Is Silo Pharma (SILO) stock a smart investment (Bullish Momentum) 2026-04-18Viral Momentum Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Form POS AMPost-Effective amendments for registration statement - ADVFN
Silo Pharma (NASDAQ: SILO) registers 5.02M shares underlying warrants; $0.60 strike - Stock Titan
[EFFECT] Silo Pharma, Inc. SEC Filing - Stock Titan
Silo Pharma (SILO) Stock: Why Technology Edge (Institutional Demand) 2026-04-15Delta Trends - UBND thành phố Hải Phòng
Silo Pharma (NASDAQ: SILO) registers 820,911 shares from July 2024 warrants - Stock Titan
Aug Weekly: Is Silo Pharma Inc a strong growth stock2026 Sector Moves & Fast Gaining Stock Reports - baoquankhu1.vn
[POS AM] Silo Pharma, Inc. SEC Filing - Stock Titan
5.78%
0.81%
大文字化:
|
ボリューム (24 時間):